Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort study

ASIA unversity > 資訊學院 > 生物資訊與醫學工程學系 > 期刊論文 > Item 310904400/99853

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/99853

Title:	Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort study
Authors:	Kok)*, 郭集慶(Victor C.;Sung), 宋鴻章(Fung-Chang;Kao), 高嘉鴻(Chia-Hung;Lin), 林則成(Che-Chen;Tseng), 曾鈞宏(Chung-Hung
Contributors:	生物資訊與醫學工程學系
Date:	2016-02
Issue Date:	2016-08-08 11:15:12 (UTC+8)
Abstract:	Background This study investigated whether patients with acquired haemolytic anaemia (AHA) would have elevated cancer risk including that for non-haematological solid tumours. We further examined whether the cancer risk would be different between patients with autoimmune type AHA (AIHA) and patients of non-AIHA. Methods Using nationwide population-based insurance claims data of Taiwan we identified a cohort of patients with AHA with no pre-existing cancer, (n = 3902) and a comparison cohort (n = 39020) without AHA, frequency-matched by gender, age, urbanization of residency and diagnosis date. Incidence and Cox method estimated adjusted hazard ratios (aHR) of cancers controlling covariates by the end of 2010 were calculated. Risks between patients with AIHA and non-AIHA were compared. Sensitivity analysis was carried out to measure the risk of cancer between patients with and without AHA by follow-up years. Results Patients with AHA had a 90 % greater incidence of cancer than controls, with an aHR of 1.78 (95 % confidence interval (CI), 1.50–2.12)]. The overall aHRs of cancer for patients with AIHA and non-AIHA were 2.01 (95 % CI, 1.56–2.59) and 1.87 (95 % CI, 1.53–2.29), respectively, compared with the comparison cohort. The aHRs for lymphatic-haematopoietic malignancy were 19.5 and 9.59 in the AIHA and non-AIHA cohorts, respectively. No hazard of colorectal, lung, liver or breast cancer was significant. Conclusions There is a near 2-fold elevated risk for subsequent cancer in patients with AHA, particularly for lymphatic-haematopoietic malignancy, which is much greater for patients with AIHA than non-AIHA. These findings can help clinicians decide patient-centred personalized long-term management.
Relation:	BMC CANCER
Appears in Collections:	[生物資訊與醫學工程學系 ] 期刊論文

Files in This Item:

File	Size	Format
index.html	0Kb	HTML	155	View/Open

Loading...